Nanoparticle-based systems imbued with both diagnostic and therapeutic functions, known
as nanotheranostics, have enabled remarkable progress in guiding focal therapy, inducing …

Auger electron (AE) radiopharmaceutical therapy (RPT) may have the same therapeutic
efficacy as α-particles for oncologic small disease, with lower risks of normal-tissue toxicity …

Metallic radionuclides possess a variety of half-lives, emission types, energies, and
branching ratios, making it possible to apply them as diagnostic and/or therapeutic agents …

Therapeutic radiopharmaceuticals have been researched extensively in the last decade as
a result of the growing research interest in personalized medicine to improve diagnostic …

The present article highlights the important progress made in the last two decades in the
fields of molecular imaging and radionuclide therapy. Advancements in radiometal-based …

Nanomedicines can integrate multiple functionalities to improve the efficacy of disease
treatment with reduced off-target toxicity. However, challenges such as tedious synthesis …

225Ac-targeted α-radiotherapy is a promising approach to treating malignancies, including
prostate cancer. However, α-emitting isotopes are difficult to image because of low …

Simple Summary Monoclonal antibody-bearing radionuclides have been under clinical
investigation over the last two decades for their use in theranostic (diagnostic and …

Radionuclides are unstable isotopes that mainly emit alpha (α), beta (β) or gamma (γ)
radiation through radiation decay. Therefore, they are used in the biomedical field to label …

Octadentate and specifically nonadentate ligands with a bispidine scaffold (3, 7-diazabicyclo
[3.3. 1] nonane) are known to be efficiently coordinated to a range of metal ions of interest in …